Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Shanghai HaiHe Biopharma patents BRD4 inhibitors

May 4, 2021

First direct KRAS G12V(ON) inhibitors developed at Revolution Medicines

May 4, 2021

FDA approves IND for KRAS G12C inhibitor JAB-21822

May 4, 2021

Repare initiates phase I trial of oral PKMYT1 inhibitor RP-6306

May 3, 2021

Monte Rosa Therapeutics discloses new protein cereblon modulators

May 3, 2021

Patient dosing begins in phase Ib/II study of CFI-400945 in leukemia

May 3, 2021

A different path to specificity for Ras inhibitors

May 3, 2021

Phase IIb/III study of masitinib in metastatic CRPC meets primary endpoint

April 30, 2021

PRT-1419 shows potent antitumor activity in preclinical models

April 30, 2021

First-in-class KAT6A/KAT6B inhibitor PF-9363 shows antitumor activity against ER+ breast cancer

April 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...